CoronaryAtlas logo
CoronaryAtlas
2-Hydroxy-6-aminopurine
Pathway / Myocardial injury (shared endpoint)

2-Hydroxy-6-aminopurine

metabolite

2-Hydroxy-6-aminopurine is a nucleotide-derived metabolite elevated in acute myocardial injury.

Pathway placement
Cascade stepMyocardial injury (shared endpoint)
Confidencelow
RationaleNovel purine metabolite associated with AMI diagnosis; mechanism unclear, likely oxidative/metabolic stress signal.
Druggability
Not assessed (no mapped human gene target).

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum, plasma or urine
Collection tube
Serum separator (gold/red-top, SST) · Lithium heparin (green-top) · Sterile urine container
Method / principle
LC-MS/MS (targeted metabolomics) or enzymatic colorimetric where available
Reagent / substrate
Stable-isotope-labeled internal standard (MS); or enzyme-coupled Trinder reagent
Platform
LC-MS/MS; some automated chemistry
Turnaround · availability
Send-out / research · Specialized / research

Literature evidence(1)